Daily cannabis news
po.tc tracks the practical cannabis stories that shape operators, investors, regulators, and suppliers: medical access, licensing, imports, tax exposure, retail structure, and the policy decisions behind them.
Latest articles
New Zealand will revoke its industrial-hemp licensing regime on 28 May, removing a compliance burden that the government says was consuming up to 13 percent of annual sector revenue in a market now worth only about NZ$1 million.
Read moreFrance has stopped admitting new medical-cannabis patients, its transition period ended on March 31, and the commercial framework notified to Brussels last year still has not produced a live market.
Read moreMissouri has opened a May comment window for new marijuana research licenses, creating a rare entry path into the state’s cannabis system even as regulators project only a small first wave.
Read moreNews feed
New Zealand is about to remove one of the central operating requirements for industrial hemp. From 28 May, activities that previously needed an industrial-hemp licence can be carried out without one for defined purposes under a...
Read moreFrance’s medical-cannabis market is still not properly open. The clearest number is also the smallest one. A Senate written question published on January 22 said that only 1,683 patients were still benefiting from the program...
Read moreMissouri is in the middle of a live rulemaking window to create marijuana research facility licenses. The proposal was published in the Missouri Register on May 1, and the Missouri Department of Health and Senior Services says...
Read moreCalifornia has opened emergency rulemaking to let cannabis retailers with one combined adult-use and medical license split that approval into two separate licenses. Under the proposal published by the Department of Cannabis...
Read moreMichigan’s marijuana rule rewrite is no longer on a straight path to adoption. On May 14, the state’s Cannabis Regulatory Agency said it had received more than 700 individual suggested changes on its proposed rules and made more...
Read moreAustralia’s medicinal-cannabis market has printed its first clear reverse. Penington Institute said in an April 2026 analysis that units sold fell to 2.65 million in the second half of 2025, down from 3.70 million in the first...
Read moreIreland has moved from talking about medical cannabis reform to formally reviewing it. On 1 April, the Department of Health announced the appointment of a chair to lead a review of access to cannabis for medical use. That...
Read more